An integrated microfluidic platform for in situ cellular cytokine secretion immunophenotyping

Department of Mechanical Engineering, University of Michigan, Ann Arbor, Michigan 48109, USA. .
Lab on a Chip (Impact Factor: 5.7). 08/2012; 12(20):4093-101. DOI: 10.1039/c2lc40619e
Source: PubMed

ABSTRACT Rapid, quantitative detection of cell-secreted biomarker proteins with a low sample volume holds great promise to advance cellular immunophenotyping techniques for personalized diagnosis and treatment of infectious diseases. Here we achieved such an assay with the THP-1 human acute moncytic leukemia cell line (a model for human monocyte) using a highly integrated microfluidic platform incorporating a no-wash bead-based chemiluminescence immunodetection scheme. Our microfluidic device allowed us to stimulate cells with lipopolysaccharide (LPS), which is an endotoxin causing septic shock due to severely pronounced immune response of the human body, under a well-controlled on-chip environment. Tumor necrosis factor-alpha (TNF-α) secreted from stimulated THP-1 cells was subsequently measured within the device with no flushing process required. Our study achieved high-sensitivity cellular immunophenotyping with 20-fold fewer cells than current cell-stimulation assay. The total assay time was also 7 times shorter than that of a conventional enzyme-linked immunosorbent assay (ELISA). Our strategy of monitoring immune cell functions in situ using a microfluidic platform could impact future medical treatments of acute infectious diseases and immune disorders by enabling a rapid, sample-efficient cellular immunophenotyping analysis.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The tumor microenvironment (TME) is a complex heterogeneous assembly composed of a variety of cell types and physical features. One such feature, hypoxia, is associated with metabolic reprogramming, the epithelial–mesenchymal transition, and therapeutic resistance. Many questions remain regarding the effects of hypoxia on these outcomes; however, only a few experimental methods enable both precise control over oxygen concentration and real-time imaging of cell behavior. Recent efforts with microfluidic platforms offer a promising solution to these limitations. In this review, we discuss conventional methods and tools used to control oxygen concentration for cell studies, and then highlight recent advances in microfluidic-based approaches for controlling oxygen in engineered platforms.
    Trends in Biotechnology 10/2014; 32(11). DOI:10.1016/j.tibtech.2014.09.006 · 10.04 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A microfluidic chip has been designed and fabricated for culture and stimulation of cells, and for subsequent cell biomarker monitoring using an on-chip performed magnetic bead-based immunoassay. As a proof of concept, we demonstrate monocytic cell (U937) culture, subsequent stimulation of the cells with lipopolysaccharide (LPS), and fluo-rescent detection of the cytokine interleukin-6 (IL6) released by the cells using magnetic beads functionalized with fluo-rescent antibodies (Abs) against IL6. The chip comprises two compartments which are separated by a vertical pillar-based filter. The immune cells are cultured in the first compartment and then differentiated to macrophages, while the second compartment is used for the immunoassay that is performed on magnetic beads, the surface of which is conjugated to an IL6-specific antibody. The magnetic beads are kept in place in the detection zone by soft magnetic tips that are part of an electromagnet circuit. The filter with a pore size of 2 m allows the released cytokines to diffuse from the cell culture / cell stimulation chamber downstream to the chamber containing the magnetic beads, but prevents an exchange of cells and magnetic beads. We found a significant increase of the fluorescence obtained from streptavidin-phycoerythrin (PE)-IL6 conjugates formed on the surface of the magnetic beads, after treating the macrophages with LPS.
    09/2014; 600(6):61-68. DOI:10.2174/1876402906666140825193215
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The available techniques for assessing blood cell functions are limited considering the various types of blood cell and their diverse functions. In the past decade, rapid advances in microengineering have enabled an array of blood cell functional measurements that are difficult or impossible to achieve using conventional bulk platforms. Such miniaturized blood cell assay platforms also provide the attractive capabilities of reducing chemical consumption, cost, and assay time, as well as exciting opportunities for device integration, automation, and assay standardization. This review summarizes these contemporary microengineered tools and discusses their promising potential for constructing accurate in vitro models and rapid clinical diagnosis using minimal amounts of whole-blood samples.
    Trends in Biotechnology 10/2014; 32(11). DOI:10.1016/j.tibtech.2014.09.003 · 10.04 Impact Factor


Available from
May 20, 2014